Is Charles River Laboratories Stock Underperforming the Dow? [Yahoo! Finance]
Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $165.00 to $190.00. They now have a "neutral" rating on the stock.
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $225.00 price target on the stock.
Charles River Laboratories International (NYSE:CRL) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort [Yahoo! Finance]